1,844
Participants
Start Date
April 11, 2017
Primary Completion Date
June 12, 2020
Study Completion Date
February 2, 2021
nivolumab
Specified Dose on Specified Days
ipilimumab
Specified Dose on Specified Days
Local Institution, Lausanne
Local Institution, Vienna
Local Institution, Brussels
Local Institution, Brussels
Local Institution, North Sydney
Local Institution, Westmead
Local Institution, Waratah
Local Institution, Melbourne
Local Institution, Melbourne
Local Institution, Box Hill
Local Institution, Tauranga
Local Institution, Liège
Local Institution, Greenslopes
Local Institution, Woolloongabba
Local Institution, Southport
Local Institution, Adelaide
Local Institution, Subiaco
Local Institution, Nedlands
Local Institution, Graz
Local Institution, Zurich
Local Institution, Dunedin
NYU Langone Medical Center, New York
Memorial Sloan Kettering Nassau, New York
Local Institution, Berlin
Laiko Hospital, Athens
Hopital De La Timone, Marseille
Ospedale Policlinico San Martino, Genova
St. Luke's University Health Network, Easton
Metropolitan Hospital, Athens
University Of Chicago, Chicago
Georgetown University Med Ctr, Washington D.C.
IRCCS Istituto Nazionale Tumori Milano, Milan
Centre Hospitalier Universitaire Dijon Bocage, Dijon
Local Institution, Buxtehude
University Of Virginia Health System, Charlottesville
Local Institution, Lübeck
ASST Papa Giovanni XXIII, Bergamo
Duke University Medical Center, Durham
Hospital Gral. Univ. Gregorio Maranon, Madrid
Carolinas Med Ctr, Charlotte
Hospital Regional Universitario De Malaga, Málaga
Winship Cancer Institute, Atlanta
Local Institution, Hanover
Institut Claudius Regaud, Toulouse
UF Health Cancer Center at Orlando Health, Orlando
Mount Sinai Comprehensive Cancer Center, Miami Beach
H. Lee Moffitt Cancer Center, Tampa
Istituto Oncologico Veneto IOV, Padua
Local Institution, Nashville
Hosp Univ Virgen Macarena, Seville
Chu Nantes, Nantes
Local Institution, Essen
Hospital Universitario Y Politecnico La Fe, Valencia
Local Institution, Tel Litwinsky
Azienda Ospedaliera Universitaria Senese, Siena
Virginia Piper Cancer Institute, Minneapolis
Mayo Clinic Rochester, Rochester
Inova Melanoma and Skin Cancer Center, Fairfax
Hopital Claude Huriez, Lille
Oncology Specialists, S.C., Park Ridge
Northwestern University, Chicago
Washington University School Of Medicine, St Louis
Local Institution, Heidelberg
Centre Hospitalier Lyon Sud, Pierre-Bénite
Local Institution, Tübingen
Texas Oncology Sammons Cancer Center, Dallas
Hopital Saint Louis, Paris
University Of Colorado, Aurora
Istituto Nazionale Tumori Fondazione Pascale, Napoli
Local Institution, München
Huntsman Cancer Institute, Salt Lake City
University of Arizona Cancer Center, Tucson
The Angeles Clinic & Research Institute, Los Angeles
Local Institution, Jerusalem
California Pacific Medical Center, San Francisco
Institut Gustave Roussy, Villejuif
Providence Cancer Center Oncology And Hematology Care, Portland
Oregon Health & Science University, Portland
Local Institution, Moscow
Sf. Nectarie Oncology Center, Craiova
Local Institution, Krasnodar
Local Institution, Krasnoyarsk
Local Institution, Haifa
Mass General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston
University Of Michigan Health System, Ann Arbor
Md Anderson Can Cnt, Houston
University Of Washington Cancer Care Alliance, Seattle
Local Institution, Ghent
Local Institution, Salvador
Local Institution, Belo Horizonte
Local Institution, Ijuí
Local Institution, Porto Alegre
Local Institution, Florianópolis
Local Institution, Barretos
Local Institution, São José do Rio Preto
Local Institution, Rio de Janeiro
Local Institution, Rio de Janeiro
Local Institution, São Paulo
Local Institution, Edmonton
Local Institution, Vancouver
Local Institution, Ottawa
Princess Margaret Cancer Centre, Toronto
Local Institution, Montreal
Local Institution, Montreal
CHU de Quebec - Universite Laval, Québec
Klinika komplexni onkologicke pece, Brno
Klinika onkologie a radioterapie, Hradec Králové
Dermatovenerologicka klinika 3. LF UK a FNKV, Prague
Dermatovenerologicka klinika VFN a 1. LF UK, Prague
Local Institution, Gera
Local Institution, Christchurch
Klinika Nowotworow Ukladowych i Uogolnionych, Krakow
Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow, Warsaw
"Institute Of Oncology Prof.Dr.Alexandru Trestioreanu Bucha", Bucharest
Hospital Universitari Germans Trias I Pujol, Badalona-barcelona
H. Univ. Vall dHebron, Barcelona
Hospital Clinic I Provincial, Barcelona
Local Institution, Oxford
The Beatson West Of Scotland Cancer Centre, Glasgow
The Royal Marsden Hospital, London
Christie Hospital Nhs Trust, Manchester
Royal Marsden Hospital - Surrey, Sutton
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY